“…Ibuprofen, a commonly used anti-inflammatory drug, is recommended for the long-term treatment of airway inflammation in cystic fibrosis lung disease (Flume, O'Sullivan, Robinson, Goss, Mogayzel, Willey-Courand, Bujan, Finder, Lester, Quittell, Rosenblatt, Vender, Hazle, Sabadosa, Hernandes, Xu & Griendling, 2018). When the balance is broken by inflammatory factors, the body will produce an oxidative stress response, leading to cell oxidative damage and development of multi-system diseases (Kruk, Aboul-Enein, Kladna & Bowser, 2019;Sies, 2015). Oxidative stress in turn activates multiple signaling pathways to induce inflammation, such as activation of NF-κB and NOD-like receptor protein 3 (NLRP3), further promoting the maturation of pro-inflammatory factors (Ahmad & Ahsan, 2020).…”